MENU
+Compare
TRDA
Stock ticker: NASDAQ
AS OF
Aug 22, 04:59 PM (EDT)
Price
$6.15
Change
+$0.28 (+4.77%)
Capitalization
223.28M

TRDA Entrada Therapeutics Forecast, Technical & Fundamental Analysis

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible... Show more

TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TRDA with price predictions
Aug 21, 2025

TRDA sees its Stochastic Oscillator ascends from oversold territory

On August 18, 2025, the Stochastic Oscillator for TRDA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 44 instances where the indicator left the oversold zone. In of the 44 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TRDA's RSI Indicator exited the oversold zone, of 17 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 21, 2025. You may want to consider a long position or call options on TRDA as a result. In of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TRDA just turned positive on August 18, 2025. Looking at past instances where TRDA's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TRDA advanced for three days, in of 240 cases, the price rose further within the following month. The odds of a continued upward trend are .

TRDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TRDA entered a downward trend on August 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.588) is normal, around the industry mean (19.773). P/E Ratio (10.259) is within average values for comparable stocks, (54.197). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.633). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (3.105) is also within normal values, averaging (300.579).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TRDA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TRDA is expected to report earnings to fall 4.81% to -99 cents per share on November 11

Entrada Therapeutics TRDA Stock Earnings Reports
Q3'25
Est.
$-0.99
Q2'25
Missed
by $0.22
Q1'25
Beat
by $0.31
Q4'24
Beat
by $0.70
Q3'24
Beat
by $0.38
The last earnings report on August 06 showed earnings per share of -103 cents, missing the estimate of -81 cents. With 70.26K shares outstanding, the current market capitalization sits at 223.28M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HVGDF0.070.01
+16.67%
Harvest Gold Corp.
MRVSY3.68N/A
N/A
Minerva S.A.
RTMNF1.49N/A
N/A
Reitmans (Canada) Limited
RPYTF155.69N/A
N/A
Reply SPA
HENOY21.29-0.23
-1.07%
Henkel AG & Co. KGAA

TRDA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+10.55%
CRNX - TRDA
54%
Loosely correlated
+1.07%
BEAM - TRDA
51%
Loosely correlated
-0.31%
XNCR - TRDA
51%
Loosely correlated
-0.93%
IDYA - TRDA
50%
Loosely correlated
+1.27%
SYRE - TRDA
50%
Loosely correlated
+2.63%
More